semaglutide launch date India's weight-loss drug boom: Novo Nordisk talks about GLP-1 generics after patent expiry Semaglutide: First Global Approval |

Patients should be aware that: Refills may be limited, and a new prescription may be required after a certain period

Based on the current evidence, GLP-1RAs should be considered alongside other guideline-directed medical therapies for HFpEF when indicated for T2D or obesity

Neither drug should be used by patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

The needle dulls after one use, the lubricant coating degrades, and the sterility is compromised

Los participantes del ensayo clnico que tomaron tirzepatida, el medicamento vendido como Zepbound, perdieron 22,8 kilogramos (50 libras) en promedio durante 72 semanas, mientras que aquellos que tomaron semaglutida, o Wegovy, perdieron alrededor de 15 kilos (33 libras), de acuerdo con el estudio financiado por Lilly y que fue publicado en el New England Journal of Medicine